AI Drug Discovery: Revolutionizing Pharma
Update: 2026-01-04
Description
Insilico Medicines AI-discovered drug, Rentosertib, is poised for phase three trials, marking a significant milestone in AI-driven drug discovery. Big pharma players like Eli Lilly are investing heavily in AI, partnering with tech giants like Nvidia and startups like Insilico. While AI promises speed and efficiency, experts caution that clinical trials will still be lengthy. The AI drug market is booming, with venture capitalists investing billions and startups like Chai Discovery raising significant funds. Checkout Solipillow.com
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
